Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 19, 2026

Mar. 19, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

GlobeNewswire

Mar. 19, 2026

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

GlobeNewswire

Mar. 19, 2026

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

GlobeNewswire

Mar. 19, 2026

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

GlobeNewswire

Mar. 19, 2026

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

GlobeNewswire

Mar. 19, 2026

Gain Therapeutics to Present at the 38th Annual ROTH Conference

GlobeNewswire

Mar. 19, 2026

Kaida BioPharma Announces Executive Leadership Team to Advance KAD-101, Built for the Ovarian Cancer Gap

GlobeNewswire

Mar. 19, 2026

$1M Donation by Lume Deodorant Founder Marks the Largest Single Gift to Fund Lobular Breast Cancer Research

GlobeNewswire

Mar. 19, 2026

Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

GlobeNewswire

Mar. 19, 2026

Teva Releases Q1 2026 Aide Memoire

GlobeNewswire

Mar. 19, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

GlobeNewswire

Mar. 19, 2026

Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 19, 2026

Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 19, 2026

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

GlobeNewswire

Mar. 19, 2026

Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2025

GlobeNewswire

Mar. 19, 2026

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

Mar. 19, 2026

Curia erweitert seine Produktionskapazitäten in Glasgow und verbessert seine Plattform zur Entwicklung von Zelllinien

GlobeNewswire

Mar. 19, 2026

Curia renforce ses capacités de production à Glasgow et consolide sa plateforme de développement de lignées cellulaires

GlobeNewswire

Mar. 19, 2026

קוריה מרחיבה את כושר הייצור של גלזגו ומשפרת את פלטפורמת פיתוח קווי התאים

GlobeNewswire

Mar. 19, 2026

Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel

GlobeNewswire